{
  "ticker": "VHL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967416",
  "id": "02967416",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250708",
  "time": "1632",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06llvhkgqwgdn9.pdf",
  "summary": "- **Capital Raising Announcement**:  \n  - **Structure**: Two-tranche Placement.  \n  - **Total Raised (Tranche 1)**: AUD $3.72 million (124,016,673 shares settled on 7 July 2025).  \n  - **Tranche 2**: Expected to settle 48 hours post-EGM (~18 August 2025), involving key investor/directors.  \n  - **Use of Proceeds**: Clinical operations, tech/platform upgrades, sales/marketing, regulatory, working capital.  \n  - **Funding Status**: Fully funded to cash flow breakeven (H2 FY2026).  \n\n(No other material information identified. Omitted: operational commentary, forward-looking statements, and background details.)",
  "usage": {
    "prompt_tokens": 1633,
    "completion_tokens": 161,
    "total_tokens": 1794,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-08T06:54:20.623724"
}